Frontiers in Cardiovascular Medicine | Cardiovascular Pharmacology and Drug Discovery

Systematic Review

Published on 25 Sep 2024

The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Dong Liu
Jin Zhang
Xiaoyu Zhang
Fengli Jiang
Yiping Wu
Beibei Yang
Xinghuan Li
Xiongxiong Fan
Han Li
Yu Sun

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1454918

3,881 views
1 citation

Original Research

Published on 24 Sep 2024

Causal relationship between novel antidiabetic drugs and ischemic stroke: a drug-targeted Mendelian randomization study

in Cardiovascular Pharmacology and Drug Discovery

Zongliang Yu
Xinyi Liu
Xue Feng
Xiaonan Zhang
Rui Gao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1449185

3,061 views

Review

Published on 23 Sep 2024

A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist

in Cardiovascular Pharmacology and Drug Discovery

Shuhui Zhai
Baisheng Ma
Weiwei Chen
Qini Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1476029

9,093 views
3 citations

Mini Review

Published on 11 Sep 2024

Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review

in Cardiovascular Pharmacology and Drug Discovery

Islam Gellani
Chunqi Qian
Shuangtao Ma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1416698

1,864 views
2 citations

Review

Published on 06 Sep 2024

Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review

in Cardiovascular Pharmacology and Drug Discovery

Domingo Pascual-Figal
Antoni Bayes-Genis

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439696

5,921 views
2 citations

Editorial

Published on 04 Sep 2024

Editorial: Nutraceuticals in cardiovascular diseases and their associated risk conditions

in Cardiovascular Pharmacology and Drug Discovery

Lamiaa Ahmed
Naufal Zagidullin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1468355

1,361 views

Brief Research Report

Published on 30 Aug 2024

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Daniel Seung Kim
Emily L. Chu
Emily E. Keamy-Minor
Ishan Dhananjay Paranjpe
Wilson L. Tang
Jack W. O’Sullivan
Yaanik B. Desai
Michael B. Liu
Elise Munsey
Kimberly Hecker

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1429230

4,597 views
6 citations

Systematic Review

Published on 15 Aug 2024

Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaochen Zhang
Qiaoyan Yan
Jiao Jiang
Hua Luo
Yu Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412944

4,373 views
2 citations

Brief Research Report

Published on 08 Aug 2024

Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass

in Cardiovascular Pharmacology and Drug Discovery

Hannah Kipka
Uwe Liebchen
Max Hübner
Georg Höfner
Otto Frey
Klaus T. Wanner
Erich Kilger
Christian Hagl
Roland Tomasi
Hanna Mannell

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1406338

1,306 views

Original Research

Published on 25 Jul 2024

Identification and validation of CCL5 as a key gene in HIV infection and pulmonary arterial hypertension

in Cardiovascular Pharmacology and Drug Discovery

Mengyue Yang
Wen Bi
Zhijie Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417701

3,507 views

Original Research

Published on 16 Jul 2024

Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Anselm A. Derda
Malin Abelmann
Kristina Sonnenschein
Jan-Thorben Sieweke
Udo Bavendiek
Johann Bauersachs
Thomas Thum
Dominik Berliner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1403422

2,977 views
1 citation

Review

Published on 08 Jul 2024

The potential therapeutic value of the natural plant compounds matrine and oxymatrine in cardiovascular diseases

in Cardiovascular Pharmacology and Drug Discovery

Shanjiang Chen
Shu Wu
Bin Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417672

2,802 views
5 citations

Review

Published on 10 Jun 2024

Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities

in Cardiovascular Pharmacology and Drug Discovery

Joseph Wayne M. Fowler
LouJin Song
Kelly Tam
Rachel J. Roth Flach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412857

5,585 views
3 citations

Review

Published on 03 Jun 2024

An overview of the treatments for hypertrophic cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Wenna Xu
Fuyu Zhu
Yue Zhang
Peng Li
Yanhui Sheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1387596

6,338 views
1 citation

Systematic Review

Published on 30 May 2024

The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Vireza Pratama
Jordan Budiono
Jarir At Thobari
Bambang Widyantoro
Vita Yanti Anggraeni
Lucia Kris Dinarti

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367442

4,045 views
3 citations

Systematic Review

Published on 23 May 2024

Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaohua Lan
Huijing Zhu
Yanjie Cao
Yue Hu
Xingman Fan
Kaijie Zhang
Mengdi Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1379765

3,522 views
2 citations